Fritextsökning
Innehållstyper
-
The first pharmaceutical for eosinophilic esophagitis approved in the U.S.
The U.S. Drug Administration has approved the drug Dupixent (dupilumab) to treat inflammation of the oesophagus of the type eosinophil esophagitis.
-
Standardisation in automation
B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...
-
Fjärrprogrammerad behandling för patienter med nervsmärta
Behandling av neuropatisk smärta i hjärna och ryggmärg kan nu följas upp och omprogrammeras på distans vid Akademiska sjukhuset i Uppsala.
-
Uncertainty about the government’s life science work
The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...
-
The new Astra Zeneca CEO: “An incredibly exciting phase”
Almost 27 years have passed since Per Alfredsson from Södertälje stepped into Astra Zeneca as a newly hired engineer. After countless different roles, including...
-
Small robots to deliver pharmaceuticals to the body
Robots that can operate inside the body and a platform that combines ultrasound with AI. These are a couple of the technologies that have qualified for a list t...
-
He is zooming in on topical preparations
According to Zelmic CEO David Sagna, topical products in drug development is a growing market, and to keep pace with the development, the company is awaiting ap...
-
Editorial: ”AI that both impresses and frightens”
”In the past, I've rarely been particularly impressed by something that was produced by AI. But this is something completely different”, Samuel Lagercrantz writ...
-
Tablet treatment for hair loss approved in the USA
The US Drug Administration has given a thumbs up for the first tablet treatment for spotty hair loss.
-
KI-forskaren studerar vår immunitet mot covid-19
Marcus Buggert forskar om hur immuniteten ser ut långsiktigt hos individer som haft covid-19. Hör honom berätta om sin forskning i videon.
-
Conference on Alzheimer’s reveals several advances in the field
In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...
-
Gothenburg, the city of life science – We are ‘Little Boston’
Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...
-
Lundbeck behind the first EU-approved intravenous migraine treatment
A preventive, intravenous treatment for migraines has been approved in the EU for the first time.
-
Life science-staden Göteborg – Vi är ”Lilla Boston”
I Västsverige satsar man på life science inom alltifrån avancerade terapiläkemedel till femtech. Samtidigt blickar aktörerna mot andra branscher för inspiration och kunskap.
-
”Det här är revolutionerande”
Diabetesförening skänker storbelopp till diabetesprojekt inom AI.
-
Medtech-företag blev årets snabbväxare
Medtech-bolaget Infosolutions toppar årets rankning från Deloitte över Sveriges snabbast växande teknikbolag. På fyra år har bolaget ökat sin omsättning med 12 815 (!) procent.
-
Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”
”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigå...
-
Faster development of reliable sample handling
Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...
-
App ökar följsamhet
Hjärtmedicin räddar liv, men det är en viktig detalj. De måste tas för att fungera. Nu visar en studie att en app hjälper patienten till ökad följsamhet.
-
Supertunna elektroder används i ny metod mot smärta
En forskargrupp vid Lunds universitet har utvecklat en ny metod mot smärta via stimulering med implanterade ultratunna mikroelektroder.
-
IVI’s Director General on establishing in Sweden: Will need up to 40 employees
The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...
-
Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?
In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.
-
Helena Strigård: The rise of the community
Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.
-
The route to vaccines for everyone: “We did not just sit around and wait”
The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...
BREAKING